Ananda Developments plc (TIDM: ANA) is pleased to announce that trading in the 329,166,666 ordinary shares of 0.2 pence each in the Company (“Ordinary Shares”) shall commence at 8.00am, today on the NEX Exchange Growth Market
Melissa Sturgess, Executive Director of Ananda commented: “We are delighted with the response to our offering. We have already built strong relationships in the medicinal cannabis space in Israel and Canada and look forward to bringing our shareholders some really interesting investments in the near future.”
Ananda was established to invest in the developing market for medicinal or therapeutic Cannabis derivatives, or related products, including but not limited to nutraceuticals, dietary supplements and cosmetic products which contain Cannabis or hemp derived cannabinoids. The Directors believe that this market is growing due to an increasing number of states in the USA, as well as other countries around the world, changing their laws to allow for products containing constituents of Medicinal Cannabis to be developed, approved and sold.
Ananda’s investment strategy is to invest in companies, projects or products that are either progressing medicinal or therapeutic Cannabis research and development or are developing or have already developed, products that contain
Cannabis-derived cannabinoids and require funding to progress work plans or commercialise products. Ananda will look to invest in companies or projects in Israel, Canada and the Netherlands.
In conjunction with Admission, Peterhouse Capital Limited has completed a placing to raise GBP930,000 (before expenses), on behalf of the Company, through the issue of 206,666,666 Ordinary Shares at a price of 0.45p per Ordinary Share.
On Admission, the interests of the Directors and their immediate families and, so far as they are aware having made due and careful enquiries, of persons connected with them (all of which are beneficial, unless otherwise stated) (so far as is known to the Directors, or could with reasonable diligence be ascertained by them), (within the meaning of sections 252 to 254 of the UKCompanies Act 2006) in the Issued Share Capital will be as follows:
All information is provided on an as-is basis. Where we allow Bloggers to publish articles on our platform please note these are not our opinions or views and we have no affiliation with the companies mentioned